UBS Maintains Buy on Cigna Group, Raises Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Buy rating on Cigna Group (NYSE:CI) and raises the price target from $385 to $400.
March 08, 2024 | 5:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Caliendo maintains a Buy rating on Cigna Group and raises the price target from $385 to $400.
The upgrade in price target by a reputable analyst like Kevin Caliendo from UBS is a strong positive signal for Cigna Group. It suggests confidence in the company's future performance and potential for stock price appreciation. This is likely to be viewed positively by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100